Nature communications

Cyanine tags on single-stranded DNA improve precise CRISPR gene editing in stem cell embryos by changing DNA packaging and chemistry

Updated

Abstract

Essence

Cyanine-modified ssODN donors improved precise CRISPR-Cas9 HDR in sensitive human stem-cell and blastoid models.

Evidence

Platform experiment across human stem cell models and 3D human blastoids found 5' cyanine ssODNs produced up to 30% HDR, a 2.5-3-fold gain over unmodified ssODNs, with a 2-3-fold survival advantage.

Caveat

The evidence is limited to laboratory stem-cell and embryo-model systems, not clinical editing or organismal development.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Competing interests: King Abdullah University of Science and Technology (KAUST) has filed a patent application related to the methods described in this study, with B.Y. and M.L. listed as inventors (U.S. Provisional Patent Application No. 63/639,573; pending PCT conversion). The application covers methods for improving CRISPR–Cas-mediated precise genome editing using chemically modified single-stranded oligodeoxynucleotide (ssODN) donors, including cyanine-modified ssODNs. The authors declare no other competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free